← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2010Last known activity
Dec 13, 2021
Timeline
2000s
- Jan 1, 2002
PhaseBio Pharmaceuticals Inc.— Founded
Drugs by trial phase (12 distinct, 18 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (8 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Clinical Deterioration
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Essential Hypertension
- Familial Primary Pulmonary Hypertension
- Heart Failure
- Hemorrhage
- Hypertension
- Inflammation
- Pneumonia
- Pulmonary Edema
- Pulmonary Valve Insufficiency
- Renal Insufficiency
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Insufficiency
- Syndrome
Recent trials (18)
- NCT05162131Lead sponsorPhase 1Dec 13, 2021
- NCT04433546Lead sponsorPhase 2Jun 26, 2020
- NCT04286438Lead sponsorPhase 3Mar 1, 2020
- NCT04122170Lead sponsorPhase 2Oct 14, 2019
- NCT03928353Lead sponsorPhase 2Apr 17, 2019
- NCT03795428Lead sponsorPhase 2Apr 10, 2019
- NCT03556020Lead sponsorPhase 2Jul 15, 2018
- NCT03492385Lead sponsorPhase 1Mar 23, 2018
- NCT03315507Lead sponsorPhase 1Oct 20, 2017
- NCT02808585Lead sponsorPhase 2Jun 1, 2016
- NCT02581657Lead sponsorPhase 2Oct 1, 2015
- NCT01873885Lead sponsorPhase 1Jun 1, 2013
- NCT01835730Lead sponsorPhase 1Apr 1, 2013
- NCT01658501Lead sponsorPhase 2Jul 1, 2012
- NCT01427257Lead sponsorPhase 1Feb 1, 2012
Details
- Founded
- Malvern, PA, US Jan 1, 2002
- Last known activity
- Dec 13, 2021